BridgeBio Oncology Therapeutics Inc.

BBOT | NASDAQ

$4.67

+$0.01 (+0.21%)

Sep 22, 2026, 10:47 AM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021
Net Income	-134.04M	7.6M	-41.69K	-3.52K	-74.33
Depreciation & Amortization	610K	n/a	n/a	n/a	n/a
Stock-Based Compensation	5.87M	271.57K	n/a	n/a	n/a
Other Working Capital	8.27M	-277.13K	15K	n/a	n/a
Other Non-Cash Items	7.23M	-8.53M	26.69K	3.52K	74.33
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	6.43M	-104.61K	15K	n/a	n/a
Operating Cash Flow	-113.89M	-763.82K	-52.08M	n/a	n/a
Capital Expenditures	-606K	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-83.93M	-184M	n/a	n/a	n/a
Sales Maturities Of Investments	157.86M	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	73.33M	-184M	n/a	n/a	n/a
Debt Repayment	n/a	-209.85K	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-12.32M	-578.55K	n/a	n/a	n/a
Financial Cash Flow	383.4M	186.46M	n/a	n/a	n/a
Net Cash Flow	342.84M	1.7M	225K	n/a	n/a
Free Cash Flow	-114.5M	-763.82K	-52.49M	n/a	n/a
Adj. Free Cash Flow	-120.37M	-1.04M	-52.49M	n/a	n/a
Maintenance CapEx	-606K	n/a	n/a	n/a	n/a
Growth CapEx	n/a	n/a	n/a	n/a	n/a
Owner Earnings	-114.5M	-763.82K	-52.08M	n/a	n/a